The investment seeks investment results, before fees and expenses, that track the performance of the LPX Direct Listed Private Equity Index (the index). The index consists of up to 30 qualifying listed private equity companies. The fund invests insecurities that ProShare Advisors believes, in combin... The investment seeks investment results, before fees and expenses, that track the performance of the LPX Direct Listed Private Equity Index (the index). The index consists of up to 30 qualifying listed private equity companies. The fund invests insecurities that ProShare Advisors believes, in combination, should track the performance of the index. It will invest at least 80% of its total assets in component securities. The fund will concentrate its investments in a particular industry or group of industries, country or region to approximately the same extent as the index is so concentrated. It is non-diversified. 詳細を表示
HILLSBOROUGH, Calif., June 2 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced that at a special meeting of stockholders held today...
HILLSBOROUGH, Calif., May 11 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced today that it has received notice from NYSE Amex LLC...
HILLSBOROUGH, Calif., May 7 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) ("Apex") announced today that a special meeting of stockholders will be held at...
HILLSBOROUGH, Calif., March 5 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) ("Apex") announced today that its board of directors has determined that...
HILLSBOROUGH, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) announced today that it has received notice from NYSE Alternext US LLC...
HILLSBOROUGH, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (AMEX:PEX) announced today that, on December 13, 2008, it entered into a letter of intent with a...
HILLSBOROUGH, Calif., Oct. 14 /PRNewswire-FirstCall/ -- In light of recent events impacting the global financial markets, Apex Bioventures Acquisition Corp. (AMEX:PEX), a publicly traded special...
Apex Bioventures Acquisition Corp. (AMEX: PEX), a publicly traded special purpose acquisition company with healthcare industry expertise, announced today its mutual agreement...
Apex Bioventures Acquisition Corp. (AMEX: PEX), a publicly traded special purpose acquisition company with healthcare industry expertise, and Dynogen Pharmaceuticals, Inc., a...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.226 | 0.791316526611 | 28.56 | 28.98 | 28.43 | 3419 | 28.72005961 | SP |
4 | 0.806 | 2.88062902073 | 27.98 | 28.98 | 27.2 | 4002 | 28.07384802 | SP |
12 | 0.326 | 1.14546732256 | 28.46 | 29.25 | 27.2 | 3827 | 28.22704822 | SP |
26 | 2.356 | 8.91411275066 | 26.43 | 29.62 | 26.43 | 3053 | 28.30487356 | SP |
52 | 0.586 | 2.0780141844 | 28.2 | 30.67 | 26.43 | 3037 | 28.81460428 | SP |
156 | -4.974 | -14.7334123223 | 33.76 | 34.545 | 23.03 | 3148 | 28.59571588 | SP |
260 | -5.7186 | -16.5734423816 | 34.5046 | 39.0115 | 17.49 | 2854 | 29.54170685 | SP |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約